annual CFO:
-$171.17M-$96.41M(-128.96%)Summary
- As of today (September 16, 2025), APGE annual cash flow from operations is -$171.17 million, with the most recent change of -$96.41 million (-128.96%) on December 31, 2024.
- During the last 3 years, APGE annual CFO has fallen by -$154.75 million (-942.03%).
- APGE annual CFO is now -942.03% below its all-time high of -$16.43 million, reached on December 31, 2022.
Performance
APGE Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$62.03M-$13.55M(-27.96%)Summary
- As of today (September 16, 2025), APGE quarterly cash flow from operations is -$62.03 million, with the most recent change of -$13.55 million (-27.96%) on June 30, 2025.
- Over the past year, APGE quarterly CFO has dropped by -$32.73 million (-111.70%).
Performance
APGE quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$220.74M-$32.73M(-17.41%)Summary
- As of today (September 16, 2025), APGE TTM cash flow from operations is -$220.74 million, with the most recent change of -$32.73 million (-17.41%) on June 30, 2025.
- Over the past year, APGE TTM CFO has dropped by -$110.17 million (-99.64%).
Performance
APGE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
APGE Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -129.0% | -111.7% | -99.6% |
| 3 y3 years | -942.0% | -100.0% | -100.0% |
| 5 y5 years | -942.0% | -100.0% | -100.0% |
APGE Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -942.0% | at low | <-9999.0% | +8.4% | <-9999.0% | at low |
| 5 y | 5-year | -942.0% | at low | <-9999.0% | +8.4% | <-9999.0% | at low |
| alltime | all time | -942.0% | at low | <-9999.0% | +8.4% | <-9999.0% | at low |
APGE Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$62.03M(+28.0%) | -$220.74M(+17.4%) |
| Mar 2025 | - | -$48.48M(-28.4%) | -$188.01M(+9.8%) |
| Dec 2024 | -$171.17M(+129.0%) | -$67.71M(+59.2%) | -$171.17M(+28.5%) |
| Sep 2024 | - | -$42.52M(+45.1%) | -$133.21M(+20.5%) |
| Jun 2024 | - | -$29.30M(-7.4%) | -$110.57M(+15.4%) |
| Mar 2024 | - | -$31.64M(+6.3%) | -$95.84M(+28.2%) |
| Dec 2023 | -$74.76M | -$29.75M(+49.7%) | -$74.76M(+66.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$19.88M(+36.4%) | -$45.01M(+39.1%) |
| Jun 2023 | - | -$14.57M(+38.0%) | -$32.37M(+81.9%) |
| Mar 2023 | - | -$10.56M(+45.9%) | -$17.80M(+145.9%) |
| Dec 2022 | -$16.43M | - | - |
| Sep 2022 | - | -$7.24M(<-9900.0%) | -$7.24M(<-9900.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00 | $0.00 |
FAQ
- What is Apogee Therapeutics, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. annual CFO year-on-year change?
- What is Apogee Therapeutics, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. quarterly CFO year-on-year change?
- What is Apogee Therapeutics, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. TTM CFO year-on-year change?
What is Apogee Therapeutics, Inc. annual cash flow from operations?
The current annual CFO of APGE is -$171.17M
What is the all time high annual CFO for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high annual cash flow from operations is -$16.43M
What is Apogee Therapeutics, Inc. annual CFO year-on-year change?
Over the past year, APGE annual cash flow from operations has changed by -$96.41M (-128.96%)
What is Apogee Therapeutics, Inc. quarterly cash flow from operations?
The current quarterly CFO of APGE is -$62.03M
What is the all time high quarterly CFO for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high quarterly cash flow from operations is $0.00
What is Apogee Therapeutics, Inc. quarterly CFO year-on-year change?
Over the past year, APGE quarterly cash flow from operations has changed by -$32.73M (-111.70%)
What is Apogee Therapeutics, Inc. TTM cash flow from operations?
The current TTM CFO of APGE is -$220.74M
What is the all time high TTM CFO for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high TTM cash flow from operations is $0.00
What is Apogee Therapeutics, Inc. TTM CFO year-on-year change?
Over the past year, APGE TTM cash flow from operations has changed by -$110.17M (-99.64%)